Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.844
-0.016 (-0.85%)
Nov 21, 2024, 2:01 PM EST - Market open
Milestone Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 122 | 72 | 169 | 276 | 200 | 392 | |
| Market Cap Growth | -24.43% | -57.49% | -38.80% | 38.33% | -49.04% | - | |
| Enterprise Value | 101 | 47 | 95 | 151 | 98 | 256 | |
| Last Close Price | 1.86 | 1.67 | 3.96 | 6.55 | 6.70 | 16.01 | |
| PS Ratio | - | 71.91 | 33.83 | 18.43 | - | - | |
| PB Ratio | 5.13 | 4.29 | 2.55 | 2.45 | 1.40 | 3.41 | |
| P/TBV Ratio | 4.19 | 4.29 | 2.55 | 2.45 | 1.40 | 3.41 | |
| EV/Sales Ratio | - | 47.19 | 18.90 | 10.05 | - | - | |
| Debt / Equity Ratio | 2.25 | 3.09 | 0.04 | 0.01 | 0.01 | 0.00 | |
| Asset Turnover | - | 0.01 | 0.05 | 0.11 | - | - | |
| Quick Ratio | 14.92 | 9.33 | 10.72 | 16.92 | 23.26 | 14.49 | |
| Current Ratio | 15.40 | 10.11 | 11.70 | 17.55 | 24.14 | 14.71 | |
| Return on Equity (ROE) | -162.87% | -143.61% | -65.26% | -33.52% | -38.73% | -55.66% | |
| Return on Assets (ROA) | -32.06% | -51.01% | -38.36% | -19.95% | -23.18% | -34.21% | |
| Return on Capital (ROIC) | -34.55% | -55.59% | -40.93% | -20.92% | -24.43% | -36.36% | |
| Earnings Yield | -34.81% | -83.00% | -34.52% | -15.50% | -25.01% | -14.08% | |
| FCF Yield | -64.72% | -31.18% | -12.02% | -25.39% | -13.15% | |
| Buyback Yield / Dilution | -31.53% | -1.19% | -1.47% | -42.56% | -85.91% | -4845.07% | |
| Total Shareholder Return | -31.53% | -1.19% | -1.47% | -42.56% | -85.91% | -4845.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.